Table 1 Clinicopathological characteristics of study participants.

From: Clinical impact of lymphocyte/C-reactive protein ratio on postoperative outcomes in patients with rectal cancer who underwent curative resection

Variables

Median [range] or N (%)

Age (years)

67 [34–93]

Sex

Male

121 (60)

Female

81 (40)

BMI (kg/m2)

22.4 ± 3.5

Tumor location

High

98 (49)

Low

104 (51)

Operative approach

Open

22 (11)

Laparoscopic

180 (89)

cT classification

cT1–2

85 (42)

cT3–4

117 (58)

cStage

I

67 (33)

II

51 (25)

III

84 (42)

CEA (ng/mL)

3.4 [0.7–332.5]

Preoperative treatment

None

167 (83)

nCRT

29 (14)

NAC

6 (3)

Operation time (minutes)

301 [53–996]

Blood loss (mL)

25 [0–900]

Histology

Well/mod, papillary

188 (93)

Poor, mucinous

9 (5)

pT classification

pT0–2

101 (50)

pT3–4

101 (50)

pN classification

Positive

56 (28)

Negative

146 (72)

Complications ≥ Clavien‒Dindo grade II

Infection

23 (13)

Anastomotic leakage

10 (6)

Ileus

9 (5)

Anastomotic bleeding

4 (2)

Others

6 (3)

Adjuvant treatment

72 (36)

  1. BMI body mass index, cT clinical stage based on tumor size and spread of cancer to nearby tissue, cStage clinical stage of cancer, CEA carcinoembryonic antigen, nCRT neoadjuvant chemoradiotherapy, NAC neoadjuvant chemotherapy, well/mod well-differentiated/moderately-differentiated, poor poorly-differentiated, pT pathological stage based on tumor size and spread of cancer to nearby tissue, pN pathological stage based on spread of cancer to nearby lymph nodes.